SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020422
Filing Date
2022-05-16
Accepted
2022-05-16 16:39:31
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q celu-10q_20220331.htm   iXBRL 10-Q 2798893
2 EX-31.1 celu-ex311_9.htm EX-31.1 21382
3 EX-31.2 celu-ex312_10.htm EX-31.2 21380
4 EX-32.1 celu-ex321_11.htm EX-32.1 10864
5 EX-32.2 celu-ex322_8.htm EX-32.2 10812
  Complete submission text file 0001564590-22-020422.txt   12588079

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celu-20220331.xsd EX-101.SCH 90315
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celu-20220331_cal.xml EX-101.CAL 61603
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220331_def.xml EX-101.DEF 326240
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220331_lab.xml EX-101.LAB 600719
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220331_pre.xml EX-101.PRE 484172
85 EXTRACTED XBRL INSTANCE DOCUMENT celu-10q_20220331_htm.xml XML 2861184
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 609-235-1010
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 22930103
SIC: 2834 Pharmaceutical Preparations